Skip to main content
Dennis Cooper, MD, Oncology, Bronx, NY

Dennis L Cooper MD

Hematologic Oncology


Professor of Medicine, Yale University

Join to View Full Profile
  • 111 E 210th StBronx, NY 10467

  • Phone+1 718-920-4826

  • Fax+1 732-235-8094

Dr. Cooper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1982 - 1983
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1979
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Medical Oncology

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1981 - 2026
  • NY State Medical License
    NY State Medical License 2022 - 2026
  • NJ State Medical License
    NJ State Medical License 2015 - 2023
  • PA State Medical License
    PA State Medical License 1982 - 1984
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up
    Dennis Cooper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: